NCT03035331 2025-05-16
Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma
Mayo Clinic
Phase 1/2 Completed
Clinical Trials
5 trialsNCT04080531 2025-02-28
Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders
Emory University
Phase 4 Completed
NCT02309515 2021-01-19
Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis
Mayo Clinic
Phase 2 Terminated
NCT01349569 2019-01-15
Allogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete Remission
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT01852591 2017-02-02
PCV13
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed